RGNX Competitors & Alternatives
Compare Regenxbio Inc with similar stocks in the same industry
Biotechnology
RGNX
Main Stock$10.03
Tradestie Score
56
Market Cap
$493.52M
Revenue Growth
-0.9%
Analyst Upside
+142.9%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.95
|
$540.97M | - | 54 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.06
|
$529.35M | 6.3 | 63 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.22
|
$512.39M | - | 57 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$36.77
|
$505.12M | 1.9 | 54 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$95.33
|
$492.21M | - | 51 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$42.14
|
$474.20M | 26.8 | 58 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$10.01
|
$468.01M | - | 62 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$21.18
|
$463.20M | - | 56 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$9.17
|
$457.09M | - | 58 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$5.77
|
$454.29M | - | 59 | Compare |
More RGNX Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2836)
226 stocks in this industry